Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 10Unknown 6Recruiting 6Withdrawn 1Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Gynecologic Surgical Procedures 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Enhanced Recovery After Surgery × Clear all
NCT04505111 2022-04-11

Prehabilitation Plus ERAS vs ERAS in Gynecological Surgery

Instituto Brasileiro de Controle do Cancer

Phase NA Withdrawn

Gynecologic Surgical Procedures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡